Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring
NCT01706146
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
59
Enrollment
OTHER
Sponsor class
Conditions
Atrial Fibrillation
Interventions
DRUG:
Non-coumadin Oral Anticoagulant
Sponsor
Northwestern University
Collaborators
[object Object]
[object Object]